CACLP - The largest IVD Expo & Conference

Osang Healthcare Get FDA Emergency Use Authorization for COVID-19 Antigen Test

Industry news | 12 April, 2022 | CACLP

Original from: 360DX


The US Food and Drug Administration this week granted separate Emergency Use Authorizations for over-the-counter SARS-CoV-2 antigen self-tests developed by Osang Healthcare.


Osang's OHC COVID-19 Antigen Self Test is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in self-collected or adult-collected anterior nasal swabs. 


About a year ago, South Korea-based Osang inked a US distribution deal for its GeneFinder COVID-19 Plus RealAmp Kit with Todos Medical.


Source: Osang Healthcare Get FDA Emergency Use Authorization for COVID-19 Antigen Test

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference